Navigation Links
New Analysis Estimates Numbers of Older U.S. Adults Who May Benefit From Statin Therapy
Date:1/14/2009

sing those data, Spatz and her co-authors estimate that another 13.9 percent (8 million) of the older population would be candidates for statin therapy under the strictest JUPITER trial criteria -- hsCRP at or above 2 milligrams per liter (mg/L) and low-density lipoprotein cholesterol (LDL) under 130 milligrams per deciliter (mg/dL), Spatz said.

She estimated that another 3 million people, or 5.3 percent of the older population, would qualify for statins under an expanded, but still plausible, treatment criteria of hsCRP at or above 2 mg/L and LDL cholesterol between 130 and 160 mg/dL.

Overall, the people who may now qualify for a statin based on JUPITER's findings share many characteristics with those who already qualify for a statin medication. The two groups were similar in age, race and socioeconomic status and had equal degrees of high blood pressure and abdominal obesity, both of which are risk factors for heart disease. Compared to people who have no indication for a statin medication, the JUPITER group was distinguishable in that they were more likely to be female and older, and to have obesity, high blood pressure and the metabolic syndrome.

"This further suggests we may be missing a group of people who in addition to having an elevated hsCRP, have other features that put them at risk for heart disease, and for whom a statin medication may be beneficial," Spatz said.

Spatz hopes her study will help provide important information for the development of future guidelines about using statin medications to reduce cardiovascular disease by providing some of the information necessary to determine whether the number of people who would get statin therapy under JUPITER criteria would be cost-effective from a public health standpoint.

Co-authors are: Maureen E. Canavan, M.P.H. and Mayur M. Desai, Ph.D., M.P.H. Individual author disclosures are available on the manuscript.

'/>"/>
SOURCE American Heart Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NicOx Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis
2. Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis
3. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
4. New Analysis Shows Troubling Trend in Triglyceride Levels May Be Linked to Rising Rates of Obesity
5. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
6. Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients
7. Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
8. Takedas Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed
9. Fralex provides update on timing of interim analysis results
10. Analysis of Earlier European Stroke Trial Supports Treatment Regimen for Viprinex(TM) in Current International Phase 3 Clinical Trials
11. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... MENLO PARK, Calif. , June 1, 2015 /PRNewswire/ ... medical device company that is providing innovative evidence-based solutions ... it has commenced an underwritten public offering of its ... by Nevro and 2,459,175 shares to be sold by ... grant the underwriters a 30-day option to purchase up ...
(Date:6/1/2015)... 2015 NEOVIA ONCOLOGY Ltd. http://www.neoviaoncology.com/ ... development and commercialization of novel, multi-function drugs for ... with the U.S. Food and Drug Administration (FDA) ... Investigational New Drug (IND) application for its lead ... the meeting, Neovia has clarified details of the ...
(Date:6/1/2015)... Novel t reatments   ... , says   GBI Research . ... will be driven primarily by the introduction of numerous premium ... either replace or combine with generic chemotherapies. Analysis ... Lung Cancer Market to 2020 - forecasts the value ...
Breaking Medicine Technology:Nevro Announces Proposed Public Offering of Common Stock 2Nevro Announces Proposed Public Offering of Common Stock 3Neovia Oncology Announces First IND Meeting 2New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 2New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 3
... connectivity enabled by Unlimited Systems Interlink integration platform, Navigating ... cancer clinics easily meet many of the HITECH Act ... and money by reducing duplicate data entry, streamlining patient ... and reduced denials. Clinics can provide patients ...
... N.J., Oct. 18, 2011 Johnson & Johnson (NYSE: ... the third quarter of 2011, an increase of 6.8% as ... 2.6% and the positive impact of currency was 4.2%.  Domestic ... of 8.3% and a positive currency impact of 8.1%. ...
Cached Medicine Technology:Navigating Cancer and Unlimited Systems Partner to Provide Cancer Clinics With IT Interoperability to Attain HITECH Act Incentives 2Johnson & Johnson Reports 2011 Third-Quarter Results 2Johnson & Johnson Reports 2011 Third-Quarter Results 3Johnson & Johnson Reports 2011 Third-Quarter Results 4Johnson & Johnson Reports 2011 Third-Quarter Results 5Johnson & Johnson Reports 2011 Third-Quarter Results 6Johnson & Johnson Reports 2011 Third-Quarter Results 7Johnson & Johnson Reports 2011 Third-Quarter Results 8Johnson & Johnson Reports 2011 Third-Quarter Results 9Johnson & Johnson Reports 2011 Third-Quarter Results 10Johnson & Johnson Reports 2011 Third-Quarter Results 11Johnson & Johnson Reports 2011 Third-Quarter Results 12Johnson & Johnson Reports 2011 Third-Quarter Results 13Johnson & Johnson Reports 2011 Third-Quarter Results 14
(Date:6/1/2015)... June 01, 2015 "This milestone opens ... were not previously able to buy and sell shares ... unsolicited orders and also make recommendations to clients as ... an ability to trade shares of our Company,” said ... and information requirements of OTCQB provides our investors greater ...
(Date:6/1/2015)... Note: Dr. Julian is available for interviews ... , A phase III trial funded by the National ... carcinoma in situ (DCIS) now have an additional tool ... (NSABP B-35/NRG Oncology) looked at more than 3,000 DCIS ... with tamoxifen to those who completed five years of ...
(Date:6/1/2015)... NY (PRWEB) June 01, 2015 For ... patients requesting celebrity features. Much like one would request ... stars’ noses, eyes, cheeks, chin and more to illustrate ... filtering apps like FaceTune are ushering in a new ... Manhattan facial plastic surgeon, Sam Rizk, MD, FACS notes ...
(Date:6/1/2015)... There’s never a good time to be sick and need ... , As of June 1, OSF HealthCare is offering ... the Internet. Patients throughout Illinois can access care whenever they ... busy. We know that getting in to see a provider ... it easier,” said Jeffry Tillery, MD, Chief Transformation Officer for ...
(Date:6/1/2015)... June 1, 2015 – Atlanta, GA – EB ... of hospital medicine, emergency medicine, and pediatric emergency medicine, ... its partnership with AgileMD to provide the content from ... mobile application format available on iPhones, iPads and ... excited about the June 1 launch of our hospital ...
Breaking Medicine News(10 mins):Health News:Content Checked Holdings Inc. Upgrades to the OTCQB Marketplace, now available for trading as CNCK 2Health News:Content Checked Holdings Inc. Upgrades to the OTCQB Marketplace, now available for trading as CNCK 3Health News:Content Checked Holdings Inc. Upgrades to the OTCQB Marketplace, now available for trading as CNCK 4Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 2Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 3Health News:Instagram Filters Launch New Facial Plastic Surgery Trend 2Health News:OSF HealthCare Now Offering OSF OnCall 2Health News:OSF HealthCare Now Offering OSF OnCall 3Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 2Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 3
... ... among winners of the 13th annual Medical Design Excellence Award given by ... pill swallowing difficulties thanks to a specially designed spout. The product has ... that they are able to ingest prescribed medications without stress or discomfort. ...
... ... Valley of the Sun, builder Carl Mulac knew he needed fresh concept, one that ... adult community that was in harmony on many different levels. In harmony with the ... the environment,” said Mulac, CEO of Joseph Carl Homes. , ...
... ... Save Children,s Lives, Fill Key Health Care Gaps Around the World , ... Westport, Conn. (Vocus) -- To address the global shortfall of 4.3 ... women who are front-line health care workers, Save the Children says in its new State ...
... than one-third of U.S. parents surveyed had delayed or refused ... -- Almost one-third of U.S. parents surveyed delayed vaccines for ... refused to have their children immunized, possibly making them more ... that children who don,t receive recommended vaccine doses by the ...
... trend, study finds , TUESDAY, May 4 (HealthDay News) -- ... the United States having an abortion increased nearly 60 percent, ... , According to the report released May 4 by the ... , The proportion of women in the overall U.S. ...
... LA (May 4, 2010) Rates of colorectal cancer ... method, according to data being presented at Digestive Disease ... older populations as well as utilization rates of virtual ... screening guidelines. DDW is the largest international gathering ...
Cached Medicine News:Health News:Oralflo Pill Swallowing Cup Wins Medical Design Excellence Award, Helps Autism Spectrum Kids and Dysphagia Sufferers Take Medications With No Problem 2Health News:Oralflo Pill Swallowing Cup Wins Medical Design Excellence Award, Helps Autism Spectrum Kids and Dysphagia Sufferers Take Medications With No Problem 3Health News:Oralflo Pill Swallowing Cup Wins Medical Design Excellence Award, Helps Autism Spectrum Kids and Dysphagia Sufferers Take Medications With No Problem 4Health News:New 55+ Active Adult Community in the Valley Sings a New Song 2Health News:New 55+ Active Adult Community in the Valley Sings a New Song 3Health News:For a Mother's Day Gift with Lasting Appeal, Invest in Women Health Workers, Says Save the Children 2Health News:For a Mother's Day Gift with Lasting Appeal, Invest in Women Health Workers, Says Save the Children 3Health News:For a Mother's Day Gift with Lasting Appeal, Invest in Women Health Workers, Says Save the Children 4Health News:Misinformation About Vaccine Safety Puts Kids at Risk of Illness 2Health News:Abortion Rates Rising Among the Poor 2Health News:Investigators examine colorectal cancer screening methods among diverse populations 2Health News:Investigators examine colorectal cancer screening methods among diverse populations 3Health News:Investigators examine colorectal cancer screening methods among diverse populations 4Health News:Investigators examine colorectal cancer screening methods among diverse populations 5Health News:Investigators examine colorectal cancer screening methods among diverse populations 6Health News:Investigators examine colorectal cancer screening methods among diverse populations 7Health News:Investigators examine colorectal cancer screening methods among diverse populations 8Health News:Investigators examine colorectal cancer screening methods among diverse populations 9Health News:Investigators examine colorectal cancer screening methods among diverse populations 10
Speculum with malleable plate to support flap during ablation of thestromal bed....
This adjustable lid speculum is angled 45 degrees and has 17 mm wire blades. It was designed to aspirate excess fluid around the eye during cataract and refractive procedures....
Adjustable wire speculum with 17 mm open blades. Lid tension adjustable throughout procedure with thumb screw control. Available with shaft straight or angled 45 degrees....
Open 13 mm blades. Screw-controlled locking mechanism. Dull finish....
Medicine Products: